Tight spatial and temporal control in dynamic basal to distal migration of epithelial inflammatory responses and infiltration of cytoprotective macrophages determine healing skin flap transplants in Mice

Annals of Surgery

Volumn 249, Issue 3, 2009, Pages 519-534

  Schürmann, Christoph ^a   Seitz, Oliver ^a   Klein, Cornelius ^b   Sader, Robert ^a   Pfeilschifter, Josef ^a   Mühl, Heiko ^a   Goren, Itamar ^a   Frank, Stefan ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Klinikum Deggendorf   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; GENOMIC DNA; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RIBONUCLEASE; RNA; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT NECROSIS; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATINOCYTE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN BIOPSY; SKIN FLAP; SKIN TRANSPLANTATION; WESTERN BLOTTING; WOUND HEALING; ANIMAL; C57BL MOUSE; DISEASE MODEL; EPITHELIUM; IMMUNOLOGY; PHYSIOLOGY; PLASTIC SURGERY;

ANIMALS; DISEASE MODELS, ANIMAL; EPITHELIUM; FEMALE; KERATINOCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; SKIN TRANSPLANTATION; SURGICAL FLAPS; WOUND HEALING;

EID: 63449101579     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31819a8d6c     Document Type: Article

References (63)

1. Daniel RK, Kerrigan CL. Principles and physiology of skin flap surgery. In: McCarthy JG, ed. Plastic Surgery. Philadelphia: Saunders 1990:225-378.
2. Grabb WC. Techniques in plastic surgery. In: Plastic Surgery. Boston: Brown Little 1986:3-74.
3. Nakatsuka T, Harii K, Asato H, et al. Analytic review of 2372 free flap transfers for head and neck reconstruction following cancer resection. J Reconstr Microsurg. 2003;19:363-368.
4. Wei FC, Demirkan F, Chen HC, et al. The outcome of failed free flaps in head and neck and extremity reconstruction: What is next in the reconstructive ladder? Plast Reconst Surg. 2001;108:1154-1160.
5. th Annual Meeting of the Society of Head and Neck Surgeons, 1990.
6. Myers MB, Cherry G. Causes of necrosis in pedicle flaps. Plast Reconstr Surg. 1968;42:43-50.
7. Kerrigan CL. Skin flap failure: pathophysiology. Plast Reconstr Surg. 1983; 72:766-777.
8. Ghali S, Butler PEM, Tepper OM, et al. Vascular delay revisited. Plast Reconstr Surg. 2007;119:1735-1744.
9. McFarlane RM, DeYoung G, Henry RA. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg. 1965;35:177-182.
10. McFarlane RM, Heagy FC, Radin S, et al. A study of the delay phenomenon in experimental pedicle flaps. Plast Reconstr Surg. 1965;35:245-262.
11. Hoeben A, Landuyt B, Highley MS, et al. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004;56:549-580.
12. Scalise A, Tucci MG, Lucarini G, et al. Local rh-VEGF administration enhances skin flap survival more than other types of rh-VEGF administration: a clinical, morphological and immunohistochemical study. Exp Dermatol. 2004;13:682-690.
13. Michlits W, Mittermayr R, Schäfer R, et al. Fibrin-embedded administration of VEGF plasmid enhances skin flap survival. Wound Repair Regen. 2007; 15:360-367.
14. Huang N, Khan A, Ashrafpour H, et al. Efficacy and mechanism of adeno-virus-mediated VEGF-165 gene therapy for augmentation of skin flap viability. Am J Physiol Heart Circ Physiol. 2006;291:H127-H137.
15. Zheng Y, Yi C, Xia W, et al. Mesenchymal stem cells transduced by vascular endothelial growth factor gene for ischemic random skin flaps. Plast Reconstr Surg. 2008;121:59-69.
16. Yi G, Xia W, Zheng Y, et al. Transplantation of endothelial progenitor cells transferred by vascular endothelial growth factor gene for vascular regeneration of ischemic flaps. J Surg Res. 2006;135:100-106.
17. Martin P. Wound healing - aiming for perfect skin regeneration. Science. 1997;276:75-81.
18. Singer AJ, Clark RAF. Cutaneous wound healing. N Engl J Med. 1999;341: 738-746.
19. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: Molecular and cellular mechanisms. J Invest Dermatol. 2007;127:514-525.
20. Wetzler C, Kämpfer H, Stallmeyer B, et al. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol. 2000;115:245-253.
21. Engelhardt E, Toksoy A, Goebeler M, et al. Chemokines IL-8, GROα, MCP-1, IP-10, and MIG are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol. 1998;153:1849-1860.
22. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003; 3:23-35.
23. Goren I, Müller E, Schiefelbein D, et al. Systemic anti-TNFα treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol. 2007;127:2259-2267.
24. Kampfer H, Pfeilschifter J, Frank S. Expressional regulation of angiopoi-etin-1 and-2 and the tie-1 and-2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest. 2001;81:361-373.
25. Frank S, Hübner G, Breier G, et al. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem. 1995;270:12607-12613.
26. Lauer G, Sollberg S, Cole M, et al. Expression and proteolysis of VEGF is increased in chronic wounds. J Invest Dermatol. 2000;115:12-18.
27. Eming S, Krieg T. Molecular mechanisms of VEGF-A action during tissue repair. J Invest Dermatol Symp Proc. 2006;11:79-86.
28. Sato Y, Ohshima T, Kondo T. Regulatory role of endogenous IL-10 in cutaneous inflammatory response of murine wound healing. Biochem Biophys Res Commun. 1999;265:194-199.
29. Ryter SW, Alam R, Choi AMK. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86:583-650.
30. Chen YC, Shen SC, Lee WR, et al. Nitric oxide and prostaglandin E2 participate in lipopolysaccaride/ interferon-gamma-induced heme oxygenase 1 and prevent RAW264.7 macrophages from UV-irradiation-induced cell death. J Cell Biochem. 2002;86:331-339.
31. Kampfer H, Kolb N, Manderscheid M, et al. Macrophage-derived heme-oxygenase-1: expression, regulation, and possible functions in skin repair. Mol Med. 2001;7:488-498.
32. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002;8:240-246.
33. DeBruyne LA, Magee JC, Buelow R, et al. Gene transfer of immunomodulatory peptides correlates with heme oxygenase-1 induction and enhanced allograft survival. Transplantation. 2000;69:120-128.
34. Frank S, Stallmeyer B, Kampfer H, et al. Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J. 1999;13: 2002-2014.
35. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162:156-159.
36. Robinson JK, Arndt KA, LeBoit PE, et al. Atlas of Cutaneous Surgery. Philadelphia: WB Saunders Company 1996:113-118.
37. Goren I, Kämpfer H, Podda M, et al. Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. Diabetes. 2003;52:2821-2832.
38. Viola A, Luster AD. Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol. 2008;48:171-197.
39. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436-445.
40. Dinarello CA. Proinflammatory cytokines. Chest. 2000;118:503-508.
41. Dinarello CA. Dissociation of transcription from translation of human IL-1beta: induction of steady state mRNA by adherence or recombinant C5a in the absence of translation. Proc Soc Exp Biol Med. 1992;200:228-232.
42. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6:422-428.
43. Hübner G, Brauchle M, Smola H, et al. Differential regulation of proinflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine. 1996;8:548-556.
44. Habib A, Bernard C, Lebret M, et al. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J Immunol. 1997;158:3845-3851.
45. Kampfer H, Brautigam L, Geisslinger G, et al. Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. J Invest Dermatol. 2003;120:880-890.
46. Hayden MS, Ghosh S. Signaling to NFκB. Genes Dev. 2004;18:2195-2224.
47. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4:E131-E136.
48. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA. 2002;99:11908-11913.
49. Fujihara Y, Koyama H, Nishiyama N, et al. Gene transfer of bFGF to recipient bed improves survival of ischemic skin flap. Br J Plast Surg. 2005;58:511-517.
50. Kane AJ, Barker JE, Mitchell GM, et al. Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival. Br J Pharmacol. 2001;132:1631-1638.
51. Furuta S, Vadiveloo P, Romeo-Meeuw R, et al. Early inducible nitric oxide synthase 2 (NOS 2) activity enhances ischaemic skin flap survival. Angio-genesis. 2004;7:33-43.
52. Gribbe Ö, Samuelson UE, Wiklund NP. Effects of nitric oxide synthase inhibition on blood flow and survival in experimental skin flaps. J Plast Reconstr Aesthetic Surg. 2007;60:287-293.
53. Frank S, Kampfer H, Wetzler C, et al. Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: a regulatory role for nitric oxide in keratinocyte-derived RANTES expression. Biochem J. 2000;347: 265-273.
54. Neufang G, Fürstenberger G, Heidt M, et al. Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci USA. 2001;98:7629-7634.
55. Avihingsanon Y, Ma N, Csizmadia E, et al. Expression of protective genes in human renal allografts: a regulatory response to injury associated with graft rejection. Transplantation. 2002;73:1079-1085.
56. Coito AJ, Shaw GD, Li J, et al. Selectin-mediated interactions regulate cytokine networks and macrophage heme oxygenase-1 induction in cardiac allograft recipients. Lab Invest. 2002;82:61-70.
57. Soares MP, Lin Y, Anrather J, et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med. 1998;4:1073-1077.
58. Harder Y, Amon M, Schramm R, et al. Heat shock preconditioning reduces ischemic tissue necrosis by heat shock protein (HSP)-32-mediated improvement of the microcirculation rather than induction of ischemic tolerance. Ann Surg. 2005;242:869-879.
59. Morse D, Pischke SE, Zhou Z, et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem. 2003;278:36993-36998.
60. Sarady J, Otterbein SL, Liu F, et al. Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol. 2002;27:739-745.
61. Petrache I, Otterbein LE, Alam J, et al. Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2000;278:L312-L319.
62. Brouard S, Otterbein LE, Anrather J, et al. Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis. J Exp Med. 2000; 192:1015-1026.
63. Kodelja V, Müller C, Tenorio S, et al. Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology. 1997; 197:478-493.